Posted by Brittany McNabb
at 9:55 AM on Friday, June 27th, 2025
Quantum BioPharma (NASDAQ: QNTM / CSE: QNTM) is now facing one of the most severe short pressure environments observed in North American markets this year. The borrow fee on QNTM shares has surged past 437% annually — roughly 1% per trading day — placing it among the highest-cost securities to short across any exchange. These fees signal that brokers are effectively out of lendable inventory and are pricing risk accordingly.
Float Scarcity Driving Volatility Risk
With fewer than 15,000 shares available for borrowing across major prime brokers, QNTM has entered what many refer to as a “locate vacuum.” The company’s public float is approximately 2.6 million shares, making it highly sensitive to buying pressure. In micro-float environments, even small bursts of covering or long-side accumulation can cause rapid price escalation due to a lack of natural sellers and tight liquidity conditions.
Dark Pool Activity Clouds Price Discovery
Adding to concerns is the high proportion of off-exchange short trading. In recent sessions, approximately 59% of QNTM’s daily volume has been routed through dark pools — private trading venues that do not display pre-trade quotes. While such routing is legal, this level of activity can obscure real demand and suppress visible momentum. In an environment where supply is tight and borrow costs are surging, dark pool dominance raises legitimate questions about whether price discovery is functioning as it should.
Echoes of Past Short-Driven Dislocations
The structural setup now surrounding QNTM bears striking similarities to prior market events that resulted in high-profile short squeezes. KaloBios (KBIO) gained over 10,000% in 2015 after its float was effectively locked and borrow availability vanished. GameStop (GME) surged 2,740% in early 2021 under conditions of high borrow fees, float constraints, and elevated short interest. Other comparables include Tilray (TLRY) and KOSS, where borrow fees exceeded 800% during moments of extreme float compression. QNTM’s current borrow rate already exceeds GME’s peak — despite having a much smaller float.
Company Fundamentals Remain Unchanged
While trading volatility has increased, Quantum BioPharma’s operational strategy and clinical programs remain firmly on track. The company recently completed Phase 1 trials for Lucid-MS, a novel treatment designed to repair myelin damage in multiple sclerosis patients. Developed in collaboration with scientists from a Harvard-affiliated teaching hospital, Lucid-MS offers a differentiated approach in a space long dominated by immune suppression therapies. Importantly, the company has made no promotional claims, has not issued new financings, and is not engaged in any stock-related marketing activity.
No Squeeze Assumptions — But Structural Tension Is Clear
A short squeeze is never guaranteed, even with elevated borrow fees and float scarcity. However, the structural tension in QNTM’s trading — characterized by near-zero share availability, high-cost borrow, and dark pool suppression — creates the potential for sudden dislocation if a trigger appears. Any combination of positive news, reduced volume, or insider accumulation could prompt a reflexive covering event in a market ill-equipped to absorb it.
Reaffirming the Need for Market Integrity
Quantum BioPharma has not commented on recent trading behavior but reaffirms its commitment to transparency, scientific advancement, and regulatory compliance. The company supports fair, orderly markets and believes that all participants — including regulators and exchanges — should remain vigilant when structural indicators point to breakdowns in natural price formation. As this situation evolves, investors, analysts, and oversight bodies are encouraged to monitor borrow fees, share availability, and trade routing closely.
Posted by Brittany McNabb
at 1:57 PM on Tuesday, May 27th, 2025
A Bold Signal of Confidence from the Helm
In an era when executive skin in the game is more often promised than proven, PyroGenesis Canada Inc. (TSX: PYR | OTCQX: PYRGF | FRA: 8PY1) stands out. CEO P. Peter Pascali has now personally invested over $10 million into the Montreal-based cleantech company, underlining a rare and compelling alignment between management conviction and shareholder interest.
The move comes amid a string of key developments for the company, including a growing $55 million contract backlog, expanding adoption of its proprietary plasma torch technologies, and recent success in producing fumed silica — a widely used industrial material — in a cleaner, more efficient way. In fiscal year 2024, the company achieved $15.7 million in revenue, marking a 27% increase over the previous year and signaling a strong return to growth across its core business segments.
PyroGenesis, a global leader in all-electric plasma solutions, operates at the intersection of industrial decarbonization, waste remediation, and advanced materials manufacturing. Its systems are being commercialized across sectors ranging from aluminum and defense to additive manufacturing and hazardous waste destruction — including aboard U.S. Navy aircraft carriers.
Strategic Milestones Backed by Founder Commitment
In a recent interview, Pascali addressed his continued investment directly, revealing that beyond recent financings, his total personal contribution now exceeds $10 million.
“I’ve increased my personal holdings over the years and reinvested heavily in the business because I believe in our long-term trajectory. This isn’t just about optics — I’m putting real capital to work,” said Pascali.
While most CEOs receive compensation in options or warrants, Pascali’s recent $5.75 million financing — in the form of a loan to the company — included no common shares. Instead, he accepted warrants as part of the package, providing upside only if the share price increases.
“I benefit only if the company succeeds. That’s the message I want to send — this isn’t about short-term gains; it’s about building something enduring,” he added.
Fumed Silica: A Breakthrough in Clean Production
One of the company’s most exciting breakthroughs is in fumed silica, a versatile material found in thousands of products — from toothpaste and cosmetics to fiber optics and lithium batteries.
In partnership with HPQ Silicon’s subsidiary, Polvere, PyroGenesis has developed a pilot-scale reactor that converts quartz into fumed silica in a single, cleaner, and more energy-efficient step — potentially eliminating hazardous chemicals and reducing energy use versus traditional methods.
Recent independent lab results confirmed that the powder produced in PyroGenesis’ system is indeed high-quality fumed silica, aligning closely with commercial standards used by industry leader Evonik.
Why This Matters:
Traditional fumed silica production is energy-intensive and environmentally harmful. PyroGenesis’ system reduces:
Capital and operating costs
CO₂ emissions
Use of hazardous feedstocks
This could disrupt a high-volume, $1+ billion global industry. Next steps include refining purity and scaling output to 50 tonnes per year — a key commercial milestone. Notably, Evonik has signed an LOI to assess samples, signaling high-level industry validation.
Electrification of Heavy Industry: Plasma Torch Adoption Accelerates
Beyond materials, PyroGenesis is pushing forward on industrial electrification using its patented plasma torch systems. These torches offer a drop-in replacement for fossil-fuel-based burners in high-temperature manufacturing environments like aluminum and steel.
Key Highlights:
Plasma torches demonstrated 45% energy savings versus legacy diesel burners
In certain trials, melting time decreased by 30%, significantly boosting productivity
Major clients include Norsk Hydro, one of the world’s largest aluminum producers, and GE Vernova, with whom PyroGenesis is exploring long-term co-development
These wins are particularly significant because they stem from rigorous, long-cycle evaluations by billion-dollar companies — further proof of the robustness and scalability of PyroGenesis’ technology.
Diversified Business Model Built for Resilience
Rather than relying on a single product or market, PyroGenesis has built a multi-legged platform, delivering solutions across three verticals:
Energy Transition & Emission Reduction
Commodity Security & Optimization
Waste Remediation
This diversified approach offers built-in stability. Should one product line underperform, others can support continued growth — a strategic model that few small-cap companies have executed successfully.
The company’s client base is equally diversified, with customers across North America, Europe, and the Middle East. Its business is also insulated from many trade-policy shocks, thanks to flexible global operations and contracts largely denominated in USD or Euros.
Conclusion: A Rare Small-Cap with Vision, Validation, and Velocity
In a market full of speculative narratives, PyroGenesis offers something different: execution.
Double-digit revenue growth year-over-year
A $55M+ contract backlog with Tier-1 clients
Successful lab-to-pilot transition in fumed silica
Early adoption of plasma torch electrification
And perhaps most important — a CEO with over $10 million of personal capital at stake
PyroGenesis may not yet be a household name, but with multiple industrial revolutions underway — from decarbonization to reshoring of critical materials — it’s a company worth watching.
As Pascali put it, “This is serious work. And we’re just getting started.”
This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)
AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.
You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.
Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.
From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
NO INVESTMENT ADVICE
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.
You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
Neither the writer of this record nor AGORACOM is an investment advisor. Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.
Posted by Brittany McNabb
at 3:38 PM on Thursday, May 15th, 2025
The biopharmaceutical company’s legal action against major financial institutions underscores the persistent issue of spoofing in financial markets.
Introduction
Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company focused on developing treatments for neurodegenerative disorders, has filed a lawsuit seeking over $700 million in damages. The legal action alleges that CIBC World Markets and RBC Dominion Securities engaged in market manipulation practices, specifically spoofing, which artificially depressed Quantum’s stock price between January 2020 and August 2024.
Understanding Spoofing and Its Impact
Spoofing is a deceptive trading practice where traders place large orders with the intent to cancel them before execution, creating a false impression of demand or supply. This manipulates market prices and can mislead other investors. The practice was outlawed under the Dodd-Frank Act in 2010 due to its potential to disrupt market integrity.
In Quantum’s case, the company alleges that such spoofing tactics led to a significant decline in its stock value, which was trading above $460 per share in January 2020. The purported manipulation not only affected the company’s market capitalization but also potentially harmed investors who relied on transparent market operations.
Legal Proceedings and Representation
Quantum BioPharma has engaged the law firms Christian Attar and Freedman Normand Friedland LLP to represent its case on a contingency basis. This arrangement indicates the legal teams’ confidence in the merits of the case and ensures that Quantum can pursue the lawsuit without immediate financial burden.
The lawsuit, filed in the U.S. District Court for the Southern District of New York, accuses the defendants of violating multiple sections of the Securities Exchange Act. Quantum has also invited shareholders who believe they were affected by the alleged spoofing to share their experiences, aiming to document the broader impact on investor confidence and market fairness.
Advancements in Multiple Sclerosis Treatment
Amidst the legal battle, Quantum continues to advance its clinical programs. The company’s lead compound, Lucid-MS, is a first-in-class, non-immunomodulatory, neuroprotective treatment for multiple sclerosis (MS). Unlike traditional MS therapies that suppress the immune system, Lucid-MS aims to protect and restore the myelin sheath surrounding nerve fibers, addressing the root cause of the disease.
In February 2025, Quantum announced the completion of its Phase 1 clinical trial for Lucid-MS, reporting that the treatment was well-tolerated with no serious adverse events. The company is now preparing to initiate Phase 2 trials, bringing it closer to offering a novel therapeutic option for MS patients.
Conclusion
Quantum BioPharma’s lawsuit against major financial institutions brings to light the ongoing challenges of ensuring market integrity in the face of sophisticated trading manipulations like spoofing. As the company seeks justice through legal channels, it remains committed to its mission of developing innovative treatments for debilitating diseases, exemplified by the progress of Lucid-MS.
Investors and industry observers will be closely monitoring the outcomes of both the legal proceedings and the clinical advancements, as they hold significant implications for market practices and medical breakthroughs alike.
This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)
AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post. You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.
Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.
Posted by Brittany McNabb
at 2:27 PM on Tuesday, April 22nd, 2025
Revolutionizing High-Altitude Logistics and Safety
In a groundbreaking development, drone technology is revolutionizing the logistics and environmental impact of Mount Everest expeditions. Recent successful trials have proven that drones can now transport essential supplies and remove waste between Everest Base Camp and higher camps—streamlining operations, enhancing safety, and reducing the environmental toll on the world’s highest peak.
A Safer Ascent: Drones Mitigate Risks for Sherpas
For decades, Sherpas have faced life-threatening conditions while carrying heavy loads—often oxygen cylinders and ladders—through the treacherous Khumbu Icefall. These missions frequently require multiple round trips through avalanche-prone terrain.
Drones are now emerging as life-saving tools. Capable of flying supplies across dangerous areas, they significantly reduce Sherpa exposure to high-risk zones, improving both expedition safety and efficiency.
Environmental Stewardship: Tackling Everest’s Waste Problem
Every climber leaves behind an estimated 8 kilograms of waste, creating an escalating ecological problem for Everest. Cleanup crews face severe conditions when hauling garbage back down the mountain.
Drone technology is offering a new solution. By airlifting waste off the slopes, drones are helping to preserve the fragile Himalayan ecosystem while easing the physical burden on human workers.
Draganfly: Powering the Future of Remote Logistics
One company at the center of this evolution is Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO). With over 25 years of innovation in drone systems and AI-powered software, Draganfly’s platforms are designed for high-stakes operations, from extreme altitudes to disaster zones.
In 2024, Draganfly reported $6.56 million in revenue, marking a pivotal year in which it delivered advanced UAV solutions across defense, public safety, and industrial sectors.
Recent Highlights for Draganfly:
Commander 3XL drone selected by the U.S. Department of Defense for autonomous tactical resupply.
Apex drone launched for military and law enforcement, featuring interference-resistant comms and AI-based navigation.
Partnered with Massachusetts DOT and Mass General Brigham for medical drone delivery pilots.
Multi-year agreement with SafeLane Global to provide landmine mapping drones in post-conflict zones like Ukraine.
Joined forces with Balko Technologies to deliver modular LiDAR drone systems for environmental and industrial surveying.
Established a Public Safety Advisory Board chaired by Homeland Security expert Paul Goldenberg.
Draganfly’s drones are engineered with modular payload systems—making them as adaptable as a Swiss Army knife. Whether conducting search and rescue missions, environmental surveys, or logistics in remote terrain, these UAVs are purpose-built for performance under pressure.
Global Impact: Everest and Beyond
What works on Everest can be adapted to other high-risk zones. The success of high-altitude drone missions sets a precedent for their deployment in disaster recovery, military logistics, infrastructure inspections, and humanitarian aid. With flexible flight ranges and payload capacities, drones can enter areas where helicopters or ground teams cannot safely operate.
Conclusion: A New Era in Remote Operations
The integration of drones into Everest operations is more than a technological milestone—it’s a preview of how unmanned aerial systems will redefine logistics and safety in the world’s most extreme environments.
As innovators like Draganfly continue to advance drone capabilities, the global potential becomes clear: smarter, safer, and more efficient solutions that not only push the limits of engineering, but also redefine what’s possible when technology meets the human spirit of exploration.
Posted by Brittany McNabb
at 2:21 PM on Tuesday, April 22nd, 2025
Revolutionizing MS Care: A New Approach Emerges
Multiple sclerosis (MS) affects about 2.8 million people worldwide, causing symptoms like tiredness, difficulty moving, and memory problems. Traditional treatments mainly focus on controlling the immune system to reduce inflammation, but they don’t always address the damage done to the protective covering around nerve fibers, which leads to ongoing disability.
Quantum BioPharma, a company focused on new treatments for brain and nerve diseases, is taking a different approach with Lucid-MS. This new compound aims to protect and even repair the nerve fiber covering, offering a fresh approach to treating MS.
Lucid-MS: A New Treatment Option
Lucid-MS is a patented compound designed to stop and even reverse the damage to the nerve fiber covering, which is a key factor in MS. Unlike current treatments that focus on controlling the immune system, Lucid-MS works to protect and restore the nerve covering without affecting the immune system.
Clinical Milestone: Phase 1 Trial Completed
In February 2025, Quantum BioPharma announced that it successfully completed the first phase of testing Lucid-MS in healthy adults. The trial tested the safety and how the body processes the compound. The results showed no serious side effects, and Lucid-MS was well-tolerated by all participants.
Dr. Andrzej Chruscinski, Vice President of Scientific and Clinical Affairs at Quantum BioPharma, said, “We’re excited that this Phase 1 trial is complete and that Lucid-MS was found to be safe and well-tolerated. This is an important step forward and sets the stage for the next phase of development.”
Moving to Phase 2: Targeting MS Patients
Now that Phase 1 is complete, Quantum BioPharma is getting ready to start Phase 2 trials to test Lucid-MS in people with MS. This phase will focus on seeing if Lucid-MS can slow or stop the damage to the nerve covering in people with MS.
CEO Zeeshan Saeed shared his excitement: “We’re very hopeful that Lucid-MS can protect the nerve covering in MS patients, which represents a new approach to treating the disease. With Phase 1 complete and the safety confirmed, we’re now ready to move on to testing it in MS patients.”
Working Together: Improving MS Diagnosis
Along with developing Lucid-MS, Quantum BioPharma is working with scientists at Massachusetts General Hospital to test a new imaging technique. This advanced scan will help doctors see the condition of the nerve covering in MS patients, giving a better way to track the disease and see how well treatments are working.
Conclusion: A Bright Future for MS Treatment
Quantum BioPharma’s work with Lucid-MS could change the way MS is treated by focusing on protecting and repairing nerve fibers, rather than just controlling the immune system. As they move forward with Phase 2 trials, both doctors and patients are eagerly awaiting what comes next.
This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)
AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post. You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.
Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.
Posted by Brittany McNabb
at 12:48 PM on Thursday, April 3rd, 2025
Renforth Resources: Positioned for Gold and Critical Mineral Success in Quebec
In a compelling new interview with AGORACOM, Renforth Resources Inc. (CSE: RFR | OTCQB: RFHRF | FSE: 9RR) CEO Nicole Brewster laid out a clear and convincing case for why this Canadian junior exploration company is exceptionally well-positioned amid record gold prices and rising global demand for critical minerals. With flagship assets in Quebec’s world-renowned Abitibi mining district, Renforth is advancing both its 100%-owned Parbec Gold Deposit and the massive Malartic Metals Package — a combined landholding that sits in one of the richest and most active mining corridors in North America.
Strategic Location Beside Mining Giants
Renforth’s Parbec Gold Project is situated directly adjacent to Agnico Eagle’s Canadian Malartic Mine, the country’s largest open-pit gold mine. The deposit already contains 280,000 ounces of gold (101,000 oz indicated, 177,000 oz inferred), with a new NI 43-101 resource estimate expected soon. This update will include 15,000 metres of additional drilling and could significantly increase the gold resource, especially with current gold prices near C$4,500/oz.
The Parbec project benefits from exceptional infrastructure: direct road access, two hydroelectric lines crossing the property, nearby toll milling facilities, and close proximity to the Glencore-owned Horn Smelter. As Brewster puts it, “It can’t get cheaper than this — the economics of development in this region are simply unbeatable.”
Malartic Metals Package: A Critical Mineral Powerhouse
Located just north of Parbec, the 300 km² Malartic Metals Package hosts the emerging 20-kilometre-long Victoria nickel-sulphide polymetallic structure. Recent metallurgical results show that the mineralization — which includes nickel, zinc, copper, cobalt, and silver — is hosted in conventional sulphide minerals, indicating potential for standard, cost-effective processing.
Initial mineralogical analysis and TOMRA sorting tests demonstrate strong early signs of recoverability and grade optimization. Brewster also confirmed that Renforth is working with SGS to determine whether its current drilling supports a maiden resource — an important step toward unlocking value in this new discovery.
In the Midst of $5.6 Billion in M&A
Renforth is surrounded by major mining players. Agnico Eagle has spent billions acquiring and consolidating deposits across the Abitibi in recent years, including the Yamana and O3 Mining deals. Parbec sits right in the middle of this activity, offering both strategic value and expansion potential to any nearby operator looking to sustain mill throughput or grow their regional footprint.
“This is a proven gold deposit, sitting beside a mine that’s going underground and needs more ore. The strategic value is obvious,” Brewster stated.
Quebec Advantage: Cost, Policy, and Market Access
Renforth’s position in Quebec provides significant advantages beyond geology. The province is routinely ranked as a top-tier mining jurisdiction globally, and the Quebec government recently introduced new stimulus programs specifically aimed at accelerating critical mineral exploration. With access to hydroelectric power, deepwater ports, rail lines, and North America’s battery manufacturing corridor, Renforth’s assets are ideally situated to capitalize on emerging resource trends.
Conclusion: Value Waiting to Be Realized
Despite world-class assets, infrastructure, and jurisdictional advantages, Brewster noted that capital has been hard to come by for juniors — and that Renforth has instead prioritized drilling and science over promotional spending. “We’ve outlined real metals in the ground that aren’t going anywhere. What we’re building is real,” she said.
With a new gold resource estimate imminent, growing strategic relevance in the critical minerals space, and near-term catalysts ahead, Renforth Resources appears to be an underappreciated player in a district that continues to deliver major value.
For those seeking exposure to gold and critical minerals in one of the most mining-friendly regions in the world, Renforth may be one to watch.
Posted by Paul Nanuwa
at 2:51 PM on Wednesday, April 2nd, 2025
Introduction:
As global markets reel from mounting trade tensions and volatile policy decisions, one trend is crystal clear—investors are turning to gold in search of stability. Gold prices have surged to record highs, recently touching $3,177 per ounce. This flight to safety is reshaping the investment landscape.
Great Atlantic Resources (GR: TSXV) is positioned in the geopolitically stable and resource-rich region of Atlantic Canada, the company is emerging as a standout player amid the growing demand for critical metals and safe-haven assets.
Industry Outlook and Great Atlantic Resources’ Trajectory:
The current gold surge—driven by tariffs, recession fears, and currency instability—has created a tailwind for exploration-focused companies. Analysts forecast gold could climb to $3,500 per ounce within 18 months. Against this backdrop, Great Atlantic Resources is gaining traction with its high-grade gold assets and diversified critical metals portfolio. Operating in Newfoundland and New Brunswick, Great Atlantic offers the dual advantage of premier geology and low political risk, situating it well within this evolving market uptrend.
Voices of Authority:
Michael Widmer, Head of Metals Research at Bank of America, notes that the surge is “almost exclusively driven” by economic policy uncertainty, further validating the move toward gold-focused strategies. Meanwhile, certified financial planner Lee Baker emphasizes gold’s enduring role as a safe-haven: “When it seems like the world is going to hell in a handbasket, gold usually appreciates.” These insights align directly with Great Atlantic’s exploration model, which seeks to capitalize on long-term demand rather than short-term hype.
Great Atlantic Resources Highlights:
In response to the rising global demand for gold and critical minerals, Great Atlantic Resources has made key strides to strengthen its diversified portfolio across Atlantic Canada:
Golden Promise Gold Project (Newfoundland) – High-Grade Gold with Copper Upside
The Golden Promise Project continues to stand out as a cornerstone asset within Newfoundland’s emerging gold district. The latest NI 43-101 Mineral Resource Estimate confirms:
119,900 ounces of gold (Inferred) at an average grade of 10.4 g/t Au
37,600 ounces of gold (Inferred) at 7.1 g/t Au
Recent trenching and sampling have further demonstrated both precious and base metal potential:
0.964 g/t gold from a glacial float boulder
0.481 g/t gold and over 1% copper from an outcrop grab sample
0.537% copper from a float sample
These results confirm Golden Promise as a dual-target project for gold and copper discovery.
Nashwaak Lake Property (New Brunswick) – High-Grade Tungsten Potential
Located just 3 km northwest of the advanced-stage Sisson Project, Great Atlantic’s Nashwaak Lake Property positions the company in a strategic tungsten corridor. Key historical intercepts include:
2.03% tungsten (2.55% WO₃) from a 2022 rock sample
0.443% tungsten (0.558% WO₃) over 0.96 meters in a 2009 drill hole
These grades exceed the global average for tungsten deposits, highlighting Nashwaak Lake’s development potential in critical metals supply.
Southwestern New Brunswick Tin-Tungsten Project – Polymetallic Discovery Platform
Covering approximately 4,100 hectares across eight mineral claims, this newly acquired land package borders known deposits and historic producers. Historical data reveals:
Tin: 20.3% tin from a 1990 float sample at the Pughole Claim
Tungsten: 1.66% W (2.09% WO₃) from a 2020 prospecting sample at Flume Ridge
Indium & Zinc: 785 ppm indium, 18.6% zinc, and 0.32% tin over 1.2 meters (WP-08-23)
Silver & Lead: >100 ppm silver, 9.76% lead, 5.64% zinc, and 0.94% tin over 0.83 meters (WP-08-24)
Lithium: Up to 3,840 ppm lithium from 2019 float samples at Pleasant Ridge North
This multi-element project is emerging as a promising hub for critical and strategic metals exploration in Atlantic Canada.
Real-world Relevance:
Great Atlantic’s projects offer more than promising grades—they represent exposure to metals fundamental to infrastructure, electrification, and economic security. In a world where diversification is key, Great Atlantic’s mix of gold and critical minerals such as tungsten, lithium, and antimony reflects a broader strategy for navigating modern volatility.
Looking Ahead with Great Atlantic Resources:
With global uncertainty fueling investor demand for tangible, resource-based value, Great Atlantic Resources is building a portfolio designed for relevance in both gold bull markets and the critical metals renaissance. The company’s exploration momentum, resource-grade assets, and strategic geography set the stage for meaningful developments in the quarters ahead.
Conclusion:
As gold continues to break records and the search for secure, high-grade assets intensifies, Great Atlantic Resources presents a compelling opportunity rooted in geology, jurisdiction, and timing. For those seeking exposure to gold with upside in critical metals, Great Atlantic is a name to watch.
This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)
AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.
You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.
Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.
From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
NO INVESTMENT ADVICE
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.
You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
Neither the writer of this record nor AGORACOM is an investment advisor. Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.
Posted by Paul Nanuwa
at 11:33 AM on Wednesday, April 2nd, 2025
Introduction:
As California spearheads a $100 million initiative to detect methane emissions using satellite technology, it signals a new chapter in how governments and industry tackle one of the most potent climate threats. Methane, which warms the atmosphere over 25 times more than carbon dioxide, is now being targeted from orbit with data that promises near real-time action. For companies like Zefiro Methane Corp. (CBOE Canada: ZEFI) (OTCQB: ZEFIF), this momentum validates a business model rooted in detection, abatement, and monetization of methane mitigation—on the ground, and increasingly, in full view of the sky. The company’s recent project completions and technology partnerships place it at the intersection of environmental necessity and profitable innovation.
Industry Outlook and Zefiro Methane Corp’s Trajectory:
California’s satellite-based methane tracking effort is a tangible reflection of broader regulatory and technological shifts that favor proactive climate monitoring. As governments adopt real-time, high-resolution emissions data, companies positioned to act on this information become essential partners in the environmental supply chain. Zefiro Methane Corp, already the largest well-plugging operator in North America, is well-positioned within this context. The company’s integration of AI and blockchain for methane detection, coupled with a growing footprint across U.S. states and Canada, positions it to benefit from an increasingly data-driven regulatory environment.
Zefiro’s work complements this shift by remediating legacy infrastructure and converting methane reductions into high-quality carbon credits. As satellite surveillance accelerates the identification of methane sources, demand for trusted remediation providers will likely follow. Zefiro’s operational scale and verified carbon credit strategy align precisely with this trajectory.
Voices of Authority:
“The effort provides information that is much closer to real time than the data now available,” said Liane Randolph, Chair of the California Air Resources Board (CARB), underscoring the importance of dynamic monitoring capabilities.
“With this new data, we’ll be able to move faster to cut harmful methane pollution,” added Governor Gavin Newsom, emphasizing the immediacy of intervention that satellite data allows.
These sentiments mirror Zefiro CEO Talal Debs’ assertion from a recent company milestone: “Zefiro will continue working with…state agencies across the country to identify and remediate sites that seriously threaten drinking water sources and other everyday necessities.”
Zefiro Methane Corp’s Highlights:
$7.5 million in Q2 Revenue: Backed by strong commercial traction, Zefiro’s revenue rose to USD $7.5 million in its most recent quarter (Q2 FY2025), reflecting 9% year-over-year growth and an 18% increase over H2 2023.
Government-Funded Contracts Across Key States: Zefiro has secured and executed state-funded environmental remediation projects, including major multi-well programs in Ohio, Texas, and most recently Pennsylvania, where one project directly restored safe drinking water for local residents.
North America’s Leading Well Plugging Operation: Through its wholly owned subsidiary, Plants & Goodwin, Zefiro deploys over 125 full-time field specialists and a fleet of proprietary rigs, making it the continent’s largest integrated methane abatement service provider.
Technology-Driven Advantage: Strategic partnerships with firms like Geolabe, Keynum, and CarbonAi have introduced AI- and blockchain-powered tools for methane leak detection, emissions quantification, and carbon credit lifecycle tracking—accelerating both operational efficiency and credit issuance.
Premium Carbon Credit Pre-Sales Secured: Zefiro has executed presale agreements for its high-quality, U.S.-originated carbon offsets with global energy traders Mercuria and EDF Trading, reinforcing the market’s confidence in its offset products and providing early monetization visibility.
These milestones signal not just operational capability, but alignment with where public and private climate strategies are headed.
Real-world Relevance:
To the average investor, methane emissions might seem like an abstract problem. But in practical terms, Zefiro’s work is analogous to sealing leaks in a massive, invisible pipeline system that spans across the United States. Every plugged well eliminates a source of toxic gas leaking into air or groundwater—like fixing a pipe that’s been quietly corroding beneath a neighborhood. As satellite eyes in the sky highlight the leaks, companies like Zefiro step in to fix them with boots on the ground. The result is healthier communities, measurable emissions reductions, and saleable environmental assets in the form of carbon credits.
Looking Ahead with Zefiro Methane Corp:
As CARB, NASA, and Planet Labs launch new methane detection capabilities, the operational field for remediation firms will widen. Zefiro’s early investment in verification standards—most recently with TÜV SÜD as its third-party validator—means it is already building credibility in a marketplace where transparency and data-backed action will be paramount. With regulatory forces and ESG markets increasingly aligned, Zefiro’s business model reflects not only a timely response but a scalable solution.
Conclusion:
California’s $100 million satellite program marks a turning point in methane accountability. It signals a future where methane emissions are no longer hidden, and where action will be expected—not just from regulators, but from responsive operators on the ground. In this environment, Zefiro Methane Corp stands out as a company with the tools, partnerships, and field experience to lead. As data flows from orbit and governments seek fast, credible intervention, Zefiro’s ability to detect, remediate, and monetize methane abatement makes it a compelling entity following the next wave of climate infrastructure.
This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)
AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.
You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.
Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.
From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
NO INVESTMENT ADVICE
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.
You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
Neither the writer of this record nor AGORACOM is an investment advisor. Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.
Posted by Paul Nanuwa
at 4:27 PM on Monday, March 31st, 2025
Introduction
As gold hits fresh all-time highs, driven by a powerful wave of safe-haven demand, companies with scalable, high-grade deposits are increasingly in the spotlight. One of the most compelling players in this landscape is Loncor Gold (TSX: LN | OTCQX: LONCF | FSE: LO5), an emerging gold explorer with a 3.66 million ounce gold resource at its Adumbi deposit in the Democratic Republic of the Congo. With gold trading above $3,150 per ounce and some forecasts suggesting it could reach $4,500 this year, Loncor’s continued drill success and proximity to Africa’s largest gold mine make it uniquely positioned to deliver.
Industry Outlook and Loncor Gold’s Trajectory
Gold’s performance in 2025 has been extraordinary. With 16% year-to-date growth and a new record high of $3,159.30 an ounce, the yellow metal is benefiting from heightened risk aversion, geopolitical tensions, and concerns about global economic stability. Major institutions like Goldman Sachs see the rally continuing, with a potential spike to $4,500 amid global tariff wars and monetary policy uncertainty.
Loncor Gold is aligned with this upward trajectory. Its flagship Adumbi deposit—the second-largest gold deposit in the DRC—is strategically located 220 kilometers southwest of the Kibali mine, owned by Barrick Gold and AngloGold Ashanti. The combination of location, grade, and growth potential places Loncor in a strong position to benefit from sustained bullish sentiment in the gold market.
Voices of Authority
Kitco reports: “Gold prices soared to more record highs overnight on keen safe-haven demand.” Meanwhile, Goldman Sachs anticipates the price “could briefly spike to $4,500 this year.” These authoritative insights reinforce the environment in which Loncor’s high-grade discoveries are being made—and the increased attractiveness of its asset base as ounces in the ground grow more valuable.
Loncor Gold’s Highlights
Loncor’s progress has been defined by focused execution and consistent delivery:
Flagship Resource Base: 3.66 million ounces at Adumbi with 1.88 million ounces categorized as indicated and 1.78 million ounces as inferred resources, making it the second-largest deposit in the DRC.
Location Advantage: Proximity to Kibali, one of the largest gold operations on the continent.
Drill Results: Recent holes (e.g., LADD028) returned high-grade intercepts such as 13.92m @ 6.01 g/t gold and 0.87m @ 82.97 g/t gold.
Exploration Upside: Drilling continues below the current $1,600/oz pit shell, targeting expansion and future underground mining potential.
Ownership: Loncor holds an 84.68% interest in the Imbo Project, giving it significant control over future development.
Compelling Valuation: Based on current gold prices, the Adumbi project’s post-tax net present value (NPV) is estimated at approximately $2 billion, underscoring its Tier-1 potential.
These achievements have helped position Loncor as one of the most promising exploration-stage companies in Africa’s gold sector.
Real-World Relevance
Loncor’s story is about more than drill holes and assays—it’s about the transformation of geological potential into economic opportunity. In a world where gold’s appeal is rising due to instability, the real value lies in scalable, high-grade, and strategically located deposits. For investors, Loncor represents a rare opportunity to gain exposure to a gold project with Tier-1 scale adjacent to some of the most productive assets on the continent.
Just as central banks, institutions, and governments turn to gold for security, retail and institutional investors alike are increasingly drawn to companies that can offer leverage to rising prices through resource expansion. Loncor sits at that intersection—backed by data, geography, and momentum.
Looking Ahead with Loncor Gold
As drilling at Adumbi continues into 2025, Loncor’s focus remains fixed on growing its resource base and advancing toward Tier-1 status. The company’s next milestones include deeper drilling, potential underground modeling, and advancing technical studies that can unlock further value. In a gold market filled with uncertainty and opportunity, Loncor offers clarity of purpose and upside potential.
Conclusion
Loncor Gold’s high-grade discoveries, strategic location beside the Kibali mine, and expanding resource base are all converging at a pivotal moment in the gold market. With prices climbing and demand for high-quality assets intensifying, Loncor is not just reacting to the market—it is actively shaping its future within it.
This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)
AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.
You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.
Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.
From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
NO INVESTMENT ADVICE
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.
You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
Neither the writer of this record nor AGORACOM is an investment advisor. Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.
Posted by Brittany McNabb
at 9:54 AM on Thursday, March 27th, 2025
New Approach Could Redefine How Multiple Sclerosis Is Treated Worldwide
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) may be on the verge of redefining treatment for multiple sclerosis (MS), a chronic neurological disorder affecting nearly 3 million people worldwide. In a compelling interview on the AGORACOM, Dr. Andrzej Chruscinski, Vice-President of Scientific and Clinical Affairs at Quantum BioPharma, detailed the company’s successful completion of its Phase 1 clinical trial for Lucid-MS, a first-in-class neuroprotective drug targeting demyelination—the core driver of MS progression.
Unlike existing treatments, which primarily focus on managing the immune system and controlling inflammation, Lucid-MS takes aim at protecting and potentially repairing the myelin sheath—the protective layer around nerve cells that degenerates in MS patients. “We’re excited about the potential of Lucid-MS to protect myelin in MS patients as it represents a new direction in the treatment of this disease,” said Quantum BioPharma CEO Zeeshan Saeed.
A Novel Solution to a Persistent Problem
Most MS therapies today only address the inflammatory aspect of the disease, leaving the underlying neurodegeneration largely unaddressed. Lucid-MS changes that narrative.
The drug works by preventing the unraveling of the myelin sheath, a process triggered by a chemical modification known as citrullination.
Developed over a decade by Dr. Lakshmi Kotra and Dr. Mario Moscarello at the University of Toronto, Lucid-MS targets this key process, aiming to halt disease progression and protect nerve communication.
The approach has already shown success in preclinical animal models.
“Think of the myelin sheath like insulation around electrical wiring. When that’s compromised, signals can’t transmit properly,” explained Dr. Chruscinski. “Our drug preserves that insulation, maintaining neural function.”
The recently completed Phase 1 trial focused on evaluating safety and pharmacokinetics in healthy participants. According to Dr. Chruscinski, “Lucid-MS was safe and well-tolerated, with no adverse events. We’re also pleased with the drug levels observed in blood, which we believe are therapeutic.”
This milestone is crucial for advancing to Phase 2, where the company will begin testing Lucid-MS in MS patients to assess efficacy.
What to Expect in Phase 2
The company is actively designing its Phase 2 trial with a projected start in Q1 2026, pending FDA clearance via an Investigational New Drug (IND) application in late 2025.
Key details under consideration:
The trial will include roughly 60 MS patients (30 receiving Lucid-MS and 30 on placebo).
Outcomes will be measured using MRI scans and clinical assessments to evaluate both biological and functional improvement.
While the exact location is yet to be confirmed, Quantum is exploring options to include Canadian sites in recognition of the drug’s Canadian origins.
Support From the Scientific Community
Feedback from global experts at major MS conferences in North America and Europe has been overwhelmingly positive. “The response has been tremendous,” said Dr. Chruscinski. “There’s a real appetite for a drug that targets neurodegeneration, which remains an unmet need in MS.”
This third-party validation underscores the broader scientific and commercial relevance of Quantum BioPharma’s work.
A Human-Centered Mission With Investor Appeal
Dr. Chruscinski also emphasized his personal motivation. “It’s exciting to be part of something that could make a real difference. I was there when the first dose was administered in our Phase 1 trial. That’s a moment I won’t forget.”
While the drug development process remains long and complex, Quantum BioPharma has achieved a significant milestone that positions the company—and Lucid-MS—at the forefront of innovation in MS treatment.
For investors, the opportunity lies in Quantum’s unique approach, successful early data, and a clearly defined path toward a potential market-shifting solution.
Conclusion: A Meaningful Milestone With a Promising Horizon
With a Phase 1 trial successfully completed and a novel therapeutic mechanism unlike anything currently on the market, Quantum BioPharma is emerging as a company to watch in the fight against multiple sclerosis. As it gears up for its Phase 2 trial and FDA engagement, the company stands at a pivotal inflection point—one that could not only deliver long-term value for investors but also reshape the future of MS care.
To hear Dr. Chruscinski explain the science, milestones, and next steps in his own words, watch the full interview here:
